News Archive
Duke Health-led researchers have discovered new information about the signaling mechanism of cells that could one day help guide development of more specific drug therapies.
AIDS Healthcare Foundation (AHF) today criticized the Obama administration, which—in a shocking repudiation of nearly thirty years of progress against the global AIDS pandemic—last Monday unveiled a global AIDS budget that takes the unprecedented step of reducing AIDS funding by approximately $214 million in fiscal year 2013. Never before has a President sought to actually reduce America's commitment to fighting the AIDS epidemic globally.
Knowledge of a newly discovered genetic disorder, which means that a person cannot produce the protein TXNIP (thioredoxin interacting protein) in their cells, can open for the development of new diabetes drugs.
ZymoGenetics, Inc. today announced positive results from a Phase 2 clinical trial in metastatic melanoma with recombinant Interleukin 21 (IL-21) as a single agent. The trial met the primary endpoint of efficacy, as measured by objective response rate or lack of early disease progression. Overall response rate was 23.1%, in evaluable patients, and median progression-free survival was 4.3 months. The results were presented at the American Society of Clinical Oncology meeting.
If a sibling commits a violent criminal act, the risk that a younger sibling may follow in their footsteps is more likely than the transmission of that behavior to an older sibling, according to a new study conducted by researchers at Virginia Commonwealth University and Lund University in Sweden.
› Verified 4 days ago